Cart
sales@molnova.com
Compound CDy9
CAS No. 952306-80-8
Compound CDy9( —— )
Catalog No. M35975 CAS No. 952306-80-8
Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 50 | In Stock |
|
| 10MG | 84 | In Stock |
|
| 25MG | 164 | In Stock |
|
| 50MG | 245 | In Stock |
|
| 100MG | 345 | In Stock |
|
| 200MG | 484 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCompound CDy9
-
NoteResearch use only, not for human use.
-
Brief DescriptionCompound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.
-
DescriptionhCAII-IN-8, an amide, is a highly selective carbonic anhydrase (CA) inhibitor with an IC50 value of 0.18 μM against hCA II.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorCarbonic Anhydrase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number952306-80-8
-
Formula Weight336.36
-
Molecular FormulaC15H16N2O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (371.63 mM; Ultrasonic )
-
SMILESC(NC1=CC(S(N)(=O)=O)=CC=C1)(=O)C2=CC(OC)=C(OC)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zahid Hussain, et al. Synthesis and Evaluation of Amide and Thiourea Derivatives as Carbonic Anhydrase (CA) Inhibitors. ACS Omega. 2022 Dec 6;7(50):47251-47264. ?
molnova catalog
related products
-
EMD57033
EMD57033 is a cardiac troponin C (cTnC) activator, a dominant Ca2+ sensitizer, which functions by binding to cardiac/slow skeletal troponin C heterodimers to promote cardiac contraction.
-
Methazolamide
Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma.
-
Levosimendan
Levosimendan is a calcium sensitizer acting through calcium-dependent binding to cardiac troponin C (cTnC), provides treatment for heart failure.
